ST-901

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameST-901
Drug Alias NameST-901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, MajorBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClexio Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSyremis Therapeutics LtdClexio Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A